Cognitive decline in individuals with high blood pressure

TLDR

The study investigates whether baseline high blood pressure and antihypertensive treatment predict cognitive decline in elderly individuals. A longitudinal population‑based study of 1,373 59‑to‑71‑year‑old residents of Nantes followed for four years, defining high blood pressure as SBP ≥ 160 mm Hg or DBP ≥ 95 mm Hg and cognitive decline as a ≥4‑point drop on the Mini‑Mental State Examination. Baseline high blood pressure increased the odds of 4‑year cognitive decline by 2.8‑fold, and untreated hypertensive patients had 4.3–6.0 times higher risk compared with 1.9–1.3 times for treated patients.

Abstract

To examine whether baseline high blood pressure and antihypertensive treatment predicts cognitive decline in elderly individuals.A longitudinal population-based study of elderly individuals (n = 1,373) in Nantes (western France) was undertaken. Individuals 59 to 71 years of age were selected from electoral rolls. High blood pressure at baseline was defined as systolic blood pressure > or =160 mm Hg or diastolic blood pressure > or =95 mm Hg. Cognitive decline was defined as a drop of 4 points or more on the Mini-Mental State Examination between baseline and the 4-year assessment.There is an association between high blood pressure at baseline and cognitive decline at the 4-year assessment (odds ratio, 2.8; 95% CI, 1.6 to 5.0). In participants with high blood pressure, the risk of cognitive decline was 4.3 (95% CI, 2.1 to 8.8) in those without antihypertensive therapy and 1.9 (95% CI, 0.8 to 4.4) in those being treated. In participants with high blood pressure both at baseline and at the 2-year assessment, the risk for untreated participants was 6.0 (95% CI, 2.4 to 15.0) compared with 1.3 (95% CI, 0.3 to 4.9) in treated participants.High blood pressure was associated with cognitive decline. In individuals with high blood pressure, cognitive decline occurred in a relatively short time period and the risk was highest in untreated hypertensive patients.